Rankings
▼
Calendar
VRCA Q1 2017 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
VRCA
Verrica Pharmaceuticals Inc.
$59M
Q1 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$570,000
Net Income
-$570,000
EPS (Diluted)
$-0.22
Cash Flow
Operating Cash Flow
-$509,000
Free Cash Flow
-$509,000
Stock-Based Comp.
$1,000
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$125,000
Cash & Equivalents
-$527,000
← FY 2017
All Quarters
Q2 2017 →
